Plasma fatty acids, oxylipins, and risk of myocardial infarction: the Singapore Chinese Health Study
Plasma fatty acids, oxylipins, and risk of myocardial infarction: the Singapore Chinese Health Study
复制标题
DOI:
10.1194/jlr.p066423
复制
发表时间:
2016-07-01
影响因子:
6.5
通讯作者:
van Dam, Rob M.
中科院分区:
文献类型:
--
作者:
Sun, Ye;Koh, Hiromi W. L.;van Dam, Rob M.
We aimed to examine the prospective association between plasma FAs, oxylipins, and risk of acute myocardial infarction (AMI) in a Singapore Chinese population. A nested case-control study with 744 incident AMI cases and 744 matched controls aged 47-83 years was conducted within the Singapore Chinese Health Study. Nineteen plasma FAs and 12 oxylipins were quantified using MS. These were grouped into 12 FA clusters and 5 oxylipin clusters using hierarchical clustering, and their associations with AMI risk were assessed. Long-chain n-3 FAs [odds ratio (OR) = 0.67 per SD increase, 95% confidence interval (CI): 0.53-0.84, P < 0.001] and stearic acid (OR = 0.65, 95% CI: 0.44-0.97, P = 0.03) were inversely associated with AMI risk, whereas arachidonic acid (AA) was positively associated with AMI risk (OR = 1.25, 95% CI: 1.03-1.52, P = 0.02) in the multivariable model with adjustment for other FAs. Further adjustment for oxylipins did not substantially change these associations. An inverse association was observed between AA-derived oxylipin, thromboxane (TX) B-2, and AMI risk (OR = 0.81, 95% CI: 0.71-0.93, P = 0.003). Circulating long-chain n-3 FAs and stearic acid were associated with a lower and AA was associated with a higher AMI risk in this Chinese population. The association between the oxylipin TXB2 and AMI requires further research.-Sun, Y., Hiromi W. L. Koh, H. Choi, W-P. Koh, J-M. Yuan, J. W. Newman, J. Su, J. Fang, C. N. Ong, and R. M. van Dam. Plasma fatty acids, oxylipins, and risk of myocardial infarction: the Singapore Chinese Health Study.